000			01910 a2200601 4500
005			20250515131710.0
264		0	_c20090107
008			200901s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2008.226 _2doi
040			_aNLM _beng _cNLM
100	1		_aNevill, T J
245	0	0	_aPredictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. _h[electronic resource]
260			_bBone marrow transplantation _cNov 2008
300			_a659-66 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAlkylating Agents _xadverse effects
650	0	4	_aEnzyme Inhibitors _xadverse effects
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xmortality
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xetiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xadverse effects
650	0	4	_aMyelodysplastic Syndromes _xetiology
650	0	4	_aNeoplasms, Second Primary _xtherapy
650	0	4	_aPrognosis
650	0	4	_aRadiotherapy _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aTopoisomerase II Inhibitors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aHogge, D E
700	1		_aToze, C L
700	1		_aNantel, S H
700	1		_aPower, M M
700	1		_aAbou Mourad, Y R
700	1		_aSong, K W
700	1		_aLavoie, J C
700	1		_aForrest, D L
700	1		_aBarnett, M J
700	1		_aShepherd, J D
700	1		_aNitta, J Y
700	1		_aWong, S
700	1		_aSutherland, H J
700	1		_aSmith, C A
773	0		_tBone marrow transplantation _gvol. 42 _gno. 10 _gp. 659-66
856	4	0	_uhttps://doi.org/10.1038/bmt.2008.226 _zAvailable from publisher's website
999			_c18154298 _d18154298